Esophagectomy

• 

  Subject Areas on Research

  • "Early" thoracic duct ligation for chylothorax after esophagectomy means "now". 
  • A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus. 
  • A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. 
  • A phase II trial for minimally invasive esophagectomy. 
  • A unique tripartite collision tumor of the esophagus: A case report. 
  • Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. 
  • An Odyssey of complications from band, to sleeve, to bypass; definitive laparoscopic completion gastrectomy with distal esophagectomy and esophagojejunostomy for persistent leak. 
  • An e-score is born. 
  • Analysis of recurrence and survival after hypopharyngeal ablative surgery with radial forearm free flap reconstruction. 
  • Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer. 
  • Comment on "Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database". 
  • Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial". 
  • Comment on "Early Feeding After Esophagectomy: Show Must Go On". 
  • Commentary: Admission is not absolution-The burden of proof remains. 
  • Commentary: Induction immunotherapy for esophageal cancer: A safe start. 
  • Commentary: Minimally invasive esophagectomy: Steady progress. 
  • Comparison Between the 2007 and 2014 American College of Cardiology/American Heart Association Guidelines on Perioperative Evaluation for Noncardiac Surgery. 
  • Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis. 
  • Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. 
  • Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. 
  • Does trainee involvement in Ivor Lewis esophagectomy impact outcomes in any way: A question looking for an answer. 
  • Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma. 
  • Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma. 
  • Endoscopy after esophagectomy: Safety demonstrated in a porcine model. 
  • Esophageal cancer. 
  • Esophagectomy outcomes at low-volume hospitals: the association between systems characteristics and mortality. 
  • Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. 
  • Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. 
  • Gastric tube volvulus following an Ivor-Lewis esophagectomy. 
  • Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. 
  • Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. 
  • Improving outcomes after esophagectomy: the importance of preventing postoperative pneumonia. 
  • In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry. 
  • Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. 
  • Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. 
  • Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB. 
  • Laparoscopic myotomy for achalasia: predictors of successful outcome after 200 cases. 
  • Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. 
  • Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer. 
  • Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. 
  • Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. 
  • New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma. 
  • No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database. 
  • Obesity and esophagectomy for esophageal cancer: is it only the high BMI that defines prognosis? 
  • Outcomes after esophagectomy: a ten-year prospective cohort. 
  • Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. 
  • Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma. 
  • Patterns of Use of Induction Therapy for T2N0 Esophageal Cancer. 
  • Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. 
  • Patterns of recurrence after trimodality therapy for esophageal cancer. 
  • Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. 
  • Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. 
  • Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model. 
  • Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. 
  • Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. 
  • Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered? 
  • Prevalence and resource utilization for vocal fold paralysis/paresis after esophagectomy. 
  • Primary malignant melanoma of the esophagus. 
  • Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma. 
  • Reducing hospital morbidity and mortality following esophagectomy. 
  • Resection of the irradiated esophagus: the impact of lymph node yield on survival. 
  • Respiratory complications after esophagectomy. 
  • Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation. 
  • Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients. 
  • Specificity of procedure volume and in-hospital mortality association. 
  • Staging of esophageal cancer by EUS: staging accuracy revisited. 
  • Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis. 
  • Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing? 
  • Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. 
  • The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy. 
  • The Effect of Timing of Adjuvant Therapy on Survival After Esophagectomy. 
  • The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis. 
  • The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis. 
  • The Society of Thoracic Surgeons Composite Score for Evaluating Esophagectomy for Esophageal Cancer. 
  • The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer. 
  • The impact of cirrhosis on esophageal cancer surgery: An up-to-date meta-analysis. 
  • The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature. 
  • Thoracoscopic versus robotic approaches: advantages and disadvantages. 
  • Transhiatal esophagogastrectomy for an isolated ovarian cancer metastasis to the esophagus. 
  • Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. 
  • Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. 
  • Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. 
  • Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. 
  • Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. 
  • Venous Thromboembolism Prophylaxis For Esophagectomy: A Survey of Practice Patterns Among Thoracic Surgeons. 
• 

  Keywords of People

  • Esclamado, Ramon Mitra, Professor Emeritus of Head and Neck Surgery and Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Uronis, Hope Elizabeth, Associate Professor of Medicine, Medicine, Medical Oncology